A detailed history of Thompson Davis & Co., Inc. transactions in Icad Inc stock. As of the latest transaction made, Thompson Davis & Co., Inc. holds 16,777 shares of ICAD stock, worth $52,008. This represents 0.02% of its overall portfolio holdings.

Number of Shares
16,777
Holding current value
$52,008
% of portfolio
0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 03, 2025

BUY
$1.39 - $2.4 $23,320 - $40,264
16,777 New
16,777 $30,000
Q4 2021

Feb 14, 2022

SELL
$6.7 - $11.38 $6,700 - $11,380
-1,000 Closed
0 $0
Q1 2018

May 02, 2018

SELL
$2.96 - $4.0 $8,880 - $12,000
-3,000 Reduced 75.0%
1,000 $3,000
Q3 2017

Oct 30, 2017

BUY
$3.3 - $4.42 $9,900 - $13,260
3,000 Added 300.0%
4,000 $18,000
Q2 2017

Aug 10, 2017

BUY
N/A
1,000
1,000 $4,000

Others Institutions Holding ICAD

About ICAD INC


  • Ticker ICAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,333,900
  • Market Cap $78.5M
  • Description
  • iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...
More about ICAD
Track This Portfolio

Track Thompson Davis & Co., Inc. Portfolio

Follow Thompson Davis & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Thompson Davis & Co., Inc. with notifications on news.